289 related articles for article (PubMed ID: 27013014)
1. Recovery of Unrelated Donors of Peripheral Blood Stem Cells versus Recovery of Unrelated Donors of Bone Marrow: A Prespecified Analysis from the Phase III Blood and Marrow Transplant Clinical Trials Network Protocol 0201.
Burns LJ; Logan BR; Chitphakdithai P; Miller JP; Drexler R; Spellman S; Switzer GE; Wingard JR; Anasetti C; Confer DL;
Biol Blood Marrow Transplant; 2016 Jun; 22(6):1108-1116. PubMed ID: 27013014
[TBL] [Abstract][Full Text] [Related]
2. Acute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor Program.
Pulsipher MA; Chitphakdithai P; Logan BR; Shaw BE; Wingard JR; Lazarus HM; Waller EK; Seftel M; Stroncek DF; Lopez AM; Maharaj D; Hematti P; O'Donnell PV; Loren AW; Leitman SF; Anderlini P; Goldstein SC; Levine JE; Navarro WH; Miller JP; Confer DL
Blood; 2013 Jan; 121(1):197-206. PubMed ID: 23109243
[TBL] [Abstract][Full Text] [Related]
3. Infections after Transplantation of Bone Marrow or Peripheral Blood Stem Cells from Unrelated Donors.
Young JH; Logan BR; Wu J; Wingard JR; Weisdorf DJ; Mudrick C; Knust K; Horowitz MM; Confer DL; Dubberke ER; Pergam SA; Marty FM; Strasfeld LM; Brown JWM; Langston AA; Schuster MG; Kaul DR; Martin SI; Anasetti C;
Biol Blood Marrow Transplant; 2016 Feb; 22(2):359-370. PubMed ID: 26409243
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the Effect of Race, Socioeconomic Status, and Center Size on Unrelated National Marrow Donor Program Donor Outcomes: Donor Toxicities Are More Common at Low-Volume Bone Marrow Collection Centers.
Shaw BE; Logan BR; Kiefer DM; Chitphakdithai P; Pedersen TL; Abdel-Azim H; Abidi MH; Akpek G; Diaz MA; Artz AS; Dandoy C; Gajewski JL; Hematti P; Kamble RT; Kasow KA; Lazarus HM; Liesveld JL; Majhail NS; O'Donnell PV; Olsson RF; Savani BN; Schears RM; Stroncek DF; Switzer GE; Williams EP; Wingard JR; Wirk BM; Confer DL; Pulsipher MA
Biol Blood Marrow Transplant; 2015 Oct; 21(10):1830-8. PubMed ID: 26116089
[TBL] [Abstract][Full Text] [Related]
5. Health-related quality of life of bone marrow versus peripheral blood stem cell donors: a prespecified subgroup analysis from a phase III RCT-BMTCTN protocol 0201.
Switzer GE; Bruce JG; Harrington D; Haagenson M; Drexler R; Foley A; Confer D; Bishop M; Anderlini P; Rowley S; Leitman SF; Anasetti C; Wingard JR
Biol Blood Marrow Transplant; 2014 Jan; 20(1):118-27. PubMed ID: 24184336
[TBL] [Abstract][Full Text] [Related]
6. Recovery and safety profiles of marrow and PBSC donors: experience of the National Marrow Donor Program.
Miller JP; Perry EH; Price TH; Bolan CD; Karanes C; Boyd TM; Chitphakdithai P; King RJ
Biol Blood Marrow Transplant; 2008 Sep; 14(9 Suppl):29-36. PubMed ID: 18721778
[TBL] [Abstract][Full Text] [Related]
7. An evaluation of the donor experience in the canadian multicenter randomized trial of bone marrow versus peripheral blood allografting.
Bredeson C; Leger C; Couban S; Simpson D; Huebsch L; Walker I; Shore T; Howson-Jan K; Panzarella T; Messner H; Barnett M; Lipton J
Biol Blood Marrow Transplant; 2004 Jun; 10(6):405-14. PubMed ID: 15148494
[TBL] [Abstract][Full Text] [Related]
8. Differences between graft product and donor side effects following bone marrow or stem cell donation.
Favre G; Beksaç M; Bacigalupo A; Ruutu T; Nagler A; Gluckman E; Russell N; Apperley J; Szer J; Bradstock K; Buzyn A; Matcham J; Gratwohl A; Schmitz N;
Bone Marrow Transplant; 2003 Nov; 32(9):873-80. PubMed ID: 14561987
[TBL] [Abstract][Full Text] [Related]
9. Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year compared to unrelated donors.
Pulsipher MA; Logan BR; Kiefer DM; Chitphakdithai P; Riches ML; Rizzo JD; Anderlini P; Leitman OF; Kobusingye H; Besser RM; Miller JP; Drexler RJ; Abdel-Mageed A; Ahmed IA; Akard LP; Artz AS; Ball ED; Bayer RL; Bigelow C; Bolwell BJ; Broun ER; Delgado DC; Duckworth K; Dvorak CC; Hahn TE; Haight AE; Hari PN; Hayes-Lattin BM; Jacobsohn DA; Jakubowski AA; Kasow KA; Lazarus HM; Liesveld JL; Linenberger M; Litzow MR; Longo W; Magalhaes-Silverman M; McCarty JM; McGuirk JP; Mori S; Parameswaran V; Prasad VK; Rowley SD; Rybka WB; Sahdev I; Schriber JR; Selby GB; Shaughnessy PJ; Shenoy S; Spitzer T; Tse WT; Uberti JP; Vusirikala M; Waller EK; Weisdorf DJ; Yanik GA; Navarro WH; Horowitz MM; Switzer GE; Confer DL; Shaw BE
Haematologica; 2019 Apr; 104(4):844-854. PubMed ID: 30381298
[TBL] [Abstract][Full Text] [Related]
10. Lower risk for serious adverse events and no increased risk for cancer after PBSC vs BM donation.
Pulsipher MA; Chitphakdithai P; Logan BR; Navarro WH; Levine JE; Miller JP; Shaw BE; O'Donnell PV; Majhail NS; Confer DL
Blood; 2014 Jun; 123(23):3655-63. PubMed ID: 24735965
[TBL] [Abstract][Full Text] [Related]
11. The Impact of Pre-Apheresis Health Related Quality of Life on Peripheral Blood Progenitor Cell Yield and Donor's Health and Outcome: Secondary Analysis of Patient-Reported Outcome Data from the RDSafe and BMT CTN 0201 Clinical Trials.
Farhadfar N; Ahn KW; Bo-Subait S; Logan B; Stefanski HE; Hsu JW; Panch S; Confer D; Liu H; Badawy SM; Beitinjaneh A; Diaz MA; Hildebrandt GC; Kelkar AH; Lazarus HM; Murthy HS; Preussler JM; Schears RM; Sharma A; van der Poel M; Bruce JG; Pulsipher MA; Shaw BE; Wingard JR; Switzer GE
Transplant Cell Ther; 2022 Sep; 28(9):603.e1-603.e7. PubMed ID: 35688325
[TBL] [Abstract][Full Text] [Related]
12. Donor Experiences of Second Marrow or Peripheral Blood Stem Cell Collection Mirror the First, but CD34
Stroncek DF; Shaw BE; Logan BR; Kiefer DM; Savani BN; Anderlini P; Bredeson CN; Hematti P; Ganguly S; Diaz MA; Abdel-Azim H; Ahmed I; Maharaj D; Seftel M; Beitinjaneh A; Seo S; Yared JA; Halter J; O'Donnell PV; Hale GA; DeFilipp Z; Lazarus H; Liesveld JL; Zhou Z; Munshi P; Olsson RF; Kasow KA; Szer J; Switzer GE; Chitphakdithai P; Shah N; Confer DL; Pulsipher MA
Biol Blood Marrow Transplant; 2018 Jan; 24(1):175-184. PubMed ID: 28958894
[TBL] [Abstract][Full Text] [Related]
13. Predonation health-related quality of life scores predict time to recovery in hematopoietic stem cell donors.
Billen A; Madrigal JA; Strydom A; Szydlo RM; Switzer GE; Shaw BE
Biol Blood Marrow Transplant; 2015 Feb; 21(2):350-6. PubMed ID: 25452034
[TBL] [Abstract][Full Text] [Related]
14. Severe short-term adverse events in related bone marrow or peripheral blood stem cell donors.
Yanagisawa R; Hirakawa T; Doki N; Ikegame K; Matsuoka KI; Fukuda T; Nakamae H; Ota S; Hiramoto N; Ishikawa J; Ara T; Tanaka M; Koga Y; Kawakita T; Maruyama Y; Kanda Y; Hino M; Atsuta Y; Yabe H; Tsukada N
Int J Hematol; 2023 Mar; 117(3):421-427. PubMed ID: 36403180
[TBL] [Abstract][Full Text] [Related]
15. Impact of Thymoglobulin by Stem Cell Source (Peripheral Blood Stem Cell or Bone Marrow) After Myeloablative Stem Cell Transplantation From HLA 10/10-Matched Unrelated Donors: A Report From the Société Française de Greffe de Moelle et de Thérapie Cellulaire.
Ravinet A; Cabrespine A; Socié G; Milpied N; Yakoub Agha I; Nguyen S; Michallet M; Menard AL; Maillard N; Mohty M; Suarez F; Huynh A; Marchand T; Deteix C; Cassuto JP; Maury S; Chevallier P; Reman O; Peffault de Latour R; Bay JO
Transplantation; 2016 Aug; 100(8):1732-9. PubMed ID: 26528768
[TBL] [Abstract][Full Text] [Related]
16. Shorter Interdonation Interval Contributes to Lower Cell Counts in Subsequent Stem Cell Donations.
Panch SR; Logan B; Sees JA; Bo-Subait S; Savani B; Shah NN; Hsu JW; Switzer G; Lazarus HM; Anderlini P; Hematti P; Confer D; Pulsipher MA; Shaw BE; Stroncek DF
Transplant Cell Ther; 2021 Jun; 27(6):503.e1-503.e8. PubMed ID: 33823169
[TBL] [Abstract][Full Text] [Related]
17. [Safety comparison of mobilization and collection of hematopoietic stem cells between related and unrelated donors].
Zhang S; Jin H; Xu LP; Liu DH; Chen H; Liang YQ; Li T; Li FX; Wang R; Kang Q; Chen YH; Zhang XH; Han W; Huang XJ; Liu KY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):1017-22. PubMed ID: 20723320
[TBL] [Abstract][Full Text] [Related]
18. [A comparative study of unrelated donor bone marrow transplantation and peripheral blood stem cell transplantation for their therapeutic effects on leukemia].
Fan ZP; Yang K; Liu QF; Sun J; Xu D; Zhang Y; Wei YQ; Ye CX; Jiang QL; Meng FY
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Oct; 26(10):1494-7, 1512. PubMed ID: 17062361
[TBL] [Abstract][Full Text] [Related]
19. Increased risk of lethal graft-versus-host disease-like syndrome after transplantation into NOD/SCID mice of human mobilized peripheral blood stem cells, as compared to bone marrow or cord blood.
Gorin NC; Piantadosi S; Stull M; Bonte H; Wingard JR; Civin C
J Hematother Stem Cell Res; 2002 Apr; 11(2):277-92. PubMed ID: 11983099
[TBL] [Abstract][Full Text] [Related]
20. Patients with acute lymphoblastic leukaemia allografted with a matched unrelated donor may have a lower survival with a peripheral blood stem cell graft compared to bone marrow.
Garderet L; Labopin M; Gorin NC; Polge E; Fouillard L; Ehninger GE; Ringden O; Finke J; Tura S; Frassoni F
Bone Marrow Transplant; 2003 Jan; 31(1):23-9. PubMed ID: 12621503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
